What Does a Lynch Syndrome Diagnosis Mean for Your Family?

Lynch syndrome is an inherited disorder caused by mutations in DNA mismatch repair genes, and it significantly raises the lifetime risk of colorectal and several other cancers. It’s passed down in an autosomal dominant pattern, so one diagnosis in the family means each first-degree relative, that’s parents, siblings, and children, carries roughly a 50% chance of the same mutation. The mutation alone doesn’t cause cancer. It just switches off one of the body’s natural DNA repair checks, and that’s really why family screening matters as much as the original diagnosis does.

According to Dr. Sandeep Nayak, Lynch syndrome screening has become a routine part of colorectal cancer workups over the last decade, with a positive result in one relative now treated as a prompt to test the whole family rather than a finding that stays filed away in one patient’s chart.

Diagnosis usually starts with the tumor itself, not a blood test, and it moves outward from there to the rest of the family.

• Tumor screening: Newly diagnosed colorectal or endometrial tumors are routinely checked for mismatch repair protein loss using immunohistochemistry, and this simple step flags who needs a closer look.
• MSI testing: Microsatellite instability testing looks at the tumor’s DNA for a specific pattern of instability that shows up when mismatch repair isn’t working properly.
• Germline testing: A confirmed positive screen leads to blood or saliva-based genetic testing for mutations in MLH1, MSH2, MSH6, PMS2, or EPCAM, which is what actually confirms Lynch syndrome.
• Genetic counseling: Because results affect the whole family tree and not just the patient, counseling before and after testing helps make sense of what a positive or uncertain result actually means.

Testing one person with cancer is really the first step toward protecting everyone in that bloodline. Colorectal cancer screening is often the next stop once mismatch repair loss is confirmed.

Not everyone needs genetic testing, but certain family patterns raise the question fast.

• Early-onset cancer: Colorectal or endometrial cancer diagnosed before age 50 is one of the strongest individual signals that Lynch syndrome could be involved.
• Multiple relatives affected: Two or more first-degree relatives with Lynch-associated cancers across different generations point toward an inherited cause rather than chance.
• Known family mutation: If a relative has already tested positive, cascade testing for that specific mutation is far simpler and cheaper than starting from scratch.
• Mixed cancer types: A family history that combines colorectal, endometrial, ovarian, or urinary tract cancers can reflect the broader Lynch syndrome spectrum, not just one cancer type.

Because the mutation doesn’t skip generations randomly, testing tends to ripple outward once one relative is confirmed. Related reading: Colonoscopy Guidelines for High-Risk Patients.

Dr. Sandeep Nayak is one of India’s most experienced colorectal surgeons, with over 20 years of specialised practice in robotic and laparoscopic rectal cancer surgery. His multidisciplinary team at KIMS Hospitals and MACS Clinic manages the full spectrum of rectal cancer treatment, including watch-and-wait protocols for patients who achieve complete clinical response, with the same rigour applied to surveillance as to surgery itself.

Patients here aren’t pushed toward the operating theatre when the evidence doesn’t support it, and they aren’t left without a safety net when it does. Decisions are made on tumour biology, response data, and what each individual patient stands to gain or lose.

1. National Cancer Institute, Genetic Testing for Lynch Syndrome. 
2. National Institutes of Health, Lynch Syndrome: An Updated Review.

This blog is intended for informational and educational purposes only. It does not constitute medical advice. Please consult a qualified medical professional for diagnosis and treatment guidance.